NRIX Competitors & Alternatives
Compare Nurix Therapeutics Inc with similar stocks in the same industry
Biotechnology
NRIX
Main Stock$18.65
Tradestie Score
64
Market Cap
$718.62M
Revenue Growth
-0.7%
Analyst Upside
+68.6%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$35.84
|
$1.97B | - | 63 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$9.97
|
$1.92B | - | 62 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$89.93
|
$1.92B | - | 52 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$75.49
|
$1.90B | 418.1 | 66 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$38.43
|
$1.84B | - | 57 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$29.35
|
$1.81B | - | 59 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$5.74
|
$1.78B | - | 56 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$20.87
|
$1.78B | - | 60 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$17.63
|
$1.74B | - | 65 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$33.41
|
$1.68B | - | 57 | Compare |
More NRIX Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2834)
221 stocks in this industry